Scalable production of pancreatic islet progenitors for diabetes cell therapies.


Embryonic stem cells (ESCs) can be an inexhaustible source of islet cells for transplantation. Previously published protocols have been characterized by low differentiation efficiency. In this study, we developed a scalable system for the growth and differentiation of hESCs towards pancreatic islets. Our results showed that hESCs can be grown on… (More)


  • Presentations referencing similar topics